Key player: US Senator Edward M. Kennedy

Key issue: Drug prices

If the Senate swings Democratic, Senator Edward M. Kennedy takes over the powerful Senate Committee on Health, Education, Labor and Pensions, which oversees the US Food and Drug Administration and the National Institutes of Health. As the co-author of a bill to tighten safety controls at the FDA, he could slow the already lengthy approval process for new drugs and devices.